Mumbai, November 07, 2025: Bayer CropScience Limited (BSE: 506285) announced today its unaudited results for the quarter (Q2) and half year (H1) ended September 30, 2025.

For Q2 ended September 30, 2025, Bayer CropScience Limited (BCSL) registered Revenue from Operations of ₹15,534 million as compared to ₹17,382 million in the corresponding period of FY 2024-25. Profit Before Tax stood at ₹2,003 million, compared to ₹1,901 million in the corresponding period of the previous financial year.

For the H1 ended September 30, 2025, BCSL reported Revenue from Operations of ₹34,680 million compared to ₹33,696 million for the corresponding period in FY 2024-25. Profit Before Tax for the H1 ended September 30, 2025, stood at ₹5,355 million, compared to ₹5,059 million for the corresponding period in FY 2024-25.

Commenting on the quarterly results, Simon Wiebusch, Vice Chairman & Managing Director and CEO, BCSL, said, “Unusually prolonged and excessive rainfall impacted our field activities and product placement, resulting in significantly lower revenue from our Crop Protection portfolio. Despite this, our corn seed business continued its growth momentum, driven by competitive hybrids, strong execution, and favorable market dynamics. This quarter’s performance underscores our resilience and adaptability in the face of external challenges. We remain focused on preparedness and disciplined execution as we head into the Rabi season.”

Vinit Jindal, Executive Director and Chief Financial Officer, Bayer CropScience Limited, added, “The Company delivered a solid performance with Profit After Tax up 12% in Q2 and 10% in H1 year-over-year. This was driven by a favorable sales mix, stabilized input costs, lower provisioning for doubtful receivables, and disciplined cost management.”

The Board of Directors at its meeting held on November 07, 2025, declared an interim dividend of ₹90/- per equity share for the financial year ending March 31, 2026, amounting to ₹4045 Million.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to www.bayer.com.

Media Contact

Snigdha Vishal

Communications, Bayer CropScience Limited

E-mail: snigdha.vishal@bayer.com

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.